Viromed Medical AG | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Viromed Medical AG

BRIEF

published on 04/10/2025 at 13:55, 7 months 24 days ago

Viromed Medical AG Partners with AMAMUS Vet for ViroCAP® VET in Veterinary Medicine

Veterinary Medicine Viromed Medical AG Cold Plasma Technology ViroCAP® VET AMAMUS Vet Partnership
PRESS RELEASE

published on 04/10/2025 at 13:50, 7 months 24 days ago

Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use
Viromed Medical AG partners with Lang Life Sciences GmbH's AMAMUS Vet for exclusive distribution of ViroCAP® VET cold plasma medical device for veterinary use in Germany, Austria, and Switzerland

Viromed Medical AG Cold Plasma Technology ViroCAP® VET Lang Life Sciences GmbH AMAMUS Vet
BRIEF

published on 04/01/2025 at 21:00, 8 months 3 days ago

Viromed Medical AG Inks Exclusive Deal with UMECO Group for Asian Market

Medical Devices Viromed Medical AG Cold Plasma Technology UMECO Group Asian Market Expansion
PRESS RELEASE

published on 04/01/2025 at 20:55, 8 months 3 days ago

Viromed Medical AG: UMECO Group acquires exclusive marketing rights in Asia for cold plasma medical devices ViroCAP® and PulmoPlas®
Viromed Medical AG partners with UMECO Group for exclusive marketing rights of ViroCAP® and PulmoPlas® cold plasma medical devices in Asia, aiming to expand their reach in ten countries

Asia Viromed Medical AG UMECO Group Cold Plasma Medical Devices Exclusive Marketing Rights
BRIEF

published on 03/14/2025 at 15:10, 8 months 21 days ago

Viromed Medical AG Announces Promising Results for PulmoPlas® in ICU Pneumonia Treatment

Healthcare Innovation Viromed Medical AG Cold Plasma Technology PulmoPlas® Ventilator Pneumonia
PRESS RELEASE

published on 03/14/2025 at 15:05, 8 months 21 days ago

Viromed Medical AG reports promising study results for PulmoPlas® in intensive care unit ventilator-associated pneumonia patients
Viromed Medical AG reports promising study results for PulmoPlas® in treating ventilator-associated pneumonia patients, showing efficacy and safety in destroying bacteria in the respiratory tract

Study Results Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology PulmoPlas
BRIEF

published on 03/07/2025 at 16:35, 8 months 28 days ago

Viromed Medical AG Expands Shareholder Base with Strategic Healthcare Investor

Private Placement Share Acquisition Strategic Investor Healthcare Investment Viromed Medical AG
PRESS RELEASE

published on 03/07/2025 at 16:30, 8 months 28 days ago

Viromed Medical AG: Strategic healthcare investor acquires further shares in private placement
Strategic healthcare investor acquires further shares in Viromed Medical AG through private placement. Majority shareholder Uwe Perbandt reallocates 900,000 shares. Investor now holds 10.62% shares

Private Placement Shareholder Strategic Investor Viromed Medical AG Healthcare Investor
BRIEF

published on 02/28/2025 at 16:05, 9 months 4 days ago

Viromed Medical AG Achieves Milestone in Multinational Collaboration

Medical Device Regulation Viromed Medical AG Cold Plasma Technology ViroCAP® PulmoPlas®
PRESS RELEASE

published on 02/28/2025 at 16:00, 9 months 4 days ago

Viromed Medical AG reaches milestone for cooperation with multinational corporation
Viromed Medical AG reaches milestone in cooperation with multinational corporation for European license rights on cold atmospheric pressure plasma in medicine, leading to production of ViroCAP® and PulmoPlas® systems

Coopération Viromed Medical AG Cold Atmospheric Pressure Plasma Multinational Corporation License Rights

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 37 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 36 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 41 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 56 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE